Beijing Hotgen Biotech Co.Ltd(688068) : covid-19 product sales and profit contribution are uncertain; Hangzhou Biotest Biotech Co.Ltd(688767) : the net profit in 2021 is expected to increase by 86% – 109% year-on-year
selected Announcements:
Beijing Hotgen Biotech Co.Ltd(688068) : covid-19 product sales and profit contribution are uncertain
E company, Beijing Hotgen Biotech Co.Ltd(688068) (688068) issued a serious abnormal volatility announcement on stock trading in January 14th. The company’s New Coronavirus antigen self testing reagent product has obtained the EU CE certification and the self testing registration / filing of the British MHRA and French ANSM. It has not yet obtained the US market access certification, and there are many similar or other testing products in the European market. The company’s products will face the risk of fierce market competition. Affected by many factors such as overseas epidemic development and epidemic prevention and control policies, market competition, path selection of international epidemic on technical products, product competitiveness and channel ability of the company, customer recognition and so on, the sales and profit contribution of the above covid-19 products are relatively uncertain.
Rayitek Hi-Tech Film Company Ltd.Shenzhen(688323) : it is proposed to issue convertible bonds and raise no more than 430 million yuan to invest in Jiaxing high-performance polyimide film project
E company news, Rayitek Hi-Tech Film Company Ltd.Shenzhen(688323) (688323) announced on January 14 that the total amount of funds raised by the company to issue convertible bonds does not exceed 430 million yuan. After deducting the issuance expenses, the net amount of funds raised is planned to be invested in Jiaxing high-performance polyimide film project, supplement working capital and repay bank loans.
Hangzhou Biotest Biotech Co.Ltd(688767) : the net profit in 2021 is expected to increase by 86% – 109% year-on-year
E company news, Hangzhou Biotest Biotech Co.Ltd(688767) (688767) disclosed the performance forecast on January 14. It is estimated that the net profit in 2021 will be 810 million yuan to 910 million yuan, with a year-on-year increase of 86.14% to 109.12%. Affected by Delta, Omicron and other variants of covid-19 virus, the number of covid-19 infection cases in Europe, Australia and other countries and regions continued to increase significantly, and the demand for covid-19 antigen detection reagent increased significantly, which directly led to the significant growth of the company’s overseas covid-19 detection reagent revenue.
Sunwoda Electronic Co.Ltd(300207) : the net profit in 2021 will increase by 0% – 20% year-on-year
E company news, Sunwoda Electronic Co.Ltd(300207) (300207) released a performance forecast on January 14. It is expected that the net profit attributable to the parent company will be RMB 802 million-962 million in 2021, with a year-on-year increase of 0% – 20%. In 2021, the company’s overall business plan was carried out in an orderly manner. With the increase of marketing efforts, the development trend of consumer cell business was good, and the sales scale continued to increase. The company’s main business income increased steadily in 2021, and the improvement of profitability led to the corresponding growth of performance.
Zhejiang Orient Gene Biotech Co.Ltd(688298) : the net profit in 2021 is expected to increase by 181% – 205%
E company news, Zhejiang Orient Gene Biotech Co.Ltd(688298) (688298) disclosed the performance forecast on January 14. It is estimated that the net profit in 2021 will be 4.72 billion yuan – 5.12 billion yuan, a year-on-year increase of 181.45% – 205.31%; The sales performance of New Coronavirus antigen rapid test reagent (including family self testing) products in the European market continued to increase significantly, prompting a substantial increase in operating performance in 2021. On the same day, the company announced that it was concerned that Citic Securities Company Limited(600030) research department issued covid-19 rapid detection plan launched in the United States, bred a new blue ocean for antigen detection and raised the target price, and made a profit forecast for the company’s performance from 2022 to 2023. The report is only the opinion of Citic Securities Company Limited(600030) research department and does not represent the position of the company. The company has not provided relevant undisclosed operating performance data to the outside world; Nor has it made any business performance forecast from 2022 to 2023.
Luoniushan Co.Ltd(000735) : pig sales revenue in December 2021 increased by 15.67% month on month
E company news, Luoniushan Co.Ltd(000735) (000735) announced on January 14 that the company sold 38100 pigs in December 2021, with a sales revenue of 75.9242 million yuan, with month on month changes of – 9.91% and 15.67% respectively, and year-on-year changes of 131.08% and 51.13% respectively. From January to December 2021, the company sold 394100 pigs, a year-on-year increase of 156.10%; The cumulative sales revenue was 829 million yuan, a year-on-year increase of 31.75%.
Zhuzhou Qianjin Pharmaceutical Co.Ltd(600479) performance express: the net profit in 2021 was 302 million yuan, with a year-on-year increase of 1.62%
E company news, Zhuzhou Qianjin Pharmaceutical Co.Ltd(600479) (600479) released a performance express on January 14. In 2021, the operating revenue was 3.665 billion yuan, a year-on-year increase of 1.06%; The net profit attributable to the parent company was 302 million yuan, a year-on-year increase of 1.62%; The basic earnings per share is 0.72 yuan.
Goldcard Smart Group Co.Ltd(300349) : the net profit in 2021 will increase by 120% – 180% year-on-year
E company news, Goldcard Smart Group Co.Ltd(300349) (300349) released a performance forecast on January 14. It is estimated that the net profit attributable to the parent company in 2021 will be RMB 245 million-312 million, with a year-on-year increase of 120% – 180%. During the reporting period, the company accelerated the layout of smart water, gas safety and other application scenarios, and achieved remarkable results in market development. The net profit attributable to the shareholders of the listed company in the current period increased significantly year-on-year, mainly due to the provision for goodwill impairment in the same period of last year.
Anhui Guofeng Plastic Industry Co.Ltd(000859) : net profit in 2021 increased by 144% year-on-year
E company news, Anhui Guofeng Plastic Industry Co.Ltd(000859) (000859) announced on January 14 that the company’s pre profit in 2021 was about 280 million yuan, a year-on-year increase of 144%. During the reporting period, the company accelerated the transformation to the strategic new material industry, strengthened the adjustment of product structure, steadily promoted the project construction, and the proportion of new material products continued to increase.
